Association Between Two Common Polymorphisms of PPARγ Gene and Metabolic Syndrome Families in a Chinese Population

被引:29
作者
Yang, Li Lan [1 ]
Hua, Qi [1 ]
Liu, Rong Kun [1 ]
Yang, Zheng [1 ]
机构
[1] Capital Univ Med Sci, Dept Cardiol, Xuanwu Hosp, Beijing 100053, Peoples R China
关键词
PPAR gamma; Polymorphism; Metabolic syndrome; Genotype; ACTIVATED-RECEPTOR-GAMMA; PRO12ALA POLYMORPHISM; PPAR-GAMMA-2; GENE; INSULIN-RESISTANCE; DECREASED RISK; JAPANESE; VARIANT; IDENTIFICATION; ADIPOGENESIS; SUBSTITUTION;
D O I
10.1016/j.arcmed.2008.11.005
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background and Aims. We investigated the association between the two common polymorphisms, C1431T and Pro12Ala of PPAR gamma gene, and metabolic syndrome (MS) in a Chinese population. Methods. We included 423 subjects with MS and families without MS. Subjects were divided into three groups: MS probands and first- and second-degree relatives of probands, spouses and controls. Each group was then divided into two subgroups according to genotype (Pro/Pro and Pro/Ala for Pro 12Ala, CC and CT + TT for 1431 C/T). Anthropometric indices, fasting plasma glucose, lipid profile, Sv1 + Rv5 of electrocardiogram and single nucleotide polymorphisms were detected. Results. Frequencies of C 1431 T genotypes, but not Pro12Ala, were different among the three groups. MS patients with Pro/Ala genotype had higher fasting blood sugar (FBS) levels and Sv1 + Rv5. Controls with Ala allele had lower total cholesterol levels. In relatives, Ala carriers had higher high-density lipoprotein cholesterol (HDL-c) levels. BMI of the different groups were not significant. MS patients with T allele had higher FBS and Sv1 + Rv5. In relatives of MS subjects, T-allele carriers had lower blood uric acid, creatinine and higher HDL-c levels and Sv1 + Rv5. Conclusions. C1431T, but not Pro12Ala polymorphisms, are associated with MS in a Chinese population. In MS patients, Ala allele and T allele are both associated with higher fasting blood sugar and higher left ventricular voltage. In controls, Ala carriers have lower total cholesterol. In MS relatives, Ala carriers had higher HDL-c levels and T-allele carriers had lower uric acid, creatinine and higher HDL-c levels and left ventricular voltage. (c) 2009 IMSS. Published by Elsevier Inc.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 40 条
  • [1] Genetic variation in PPARG encoding peroxisome proliferator-activated receptor γ associated with carotid atherosclerosis
    Al-Shali, KZ
    House, AA
    Hanley, AJG
    Khan, HMR
    Harris, SB
    Zinman, B
    Mamakeesick, M
    Fenster, A
    Spence, JD
    Hegele, RA
    [J]. STROKE, 2004, 35 (09) : 2036 - 2040
  • [2] The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
    Altshuler, D
    Hirschhorn, JN
    Klannemark, M
    Lindgren, CM
    Vohl, MC
    Nemesh, J
    Lane, CR
    Schaffner, SF
    Bolk, S
    Brewer, C
    Tuomi, T
    Gaudet, D
    Hudson, TJ
    Daly, M
    Groop, L
    Lander, ES
    [J]. NATURE GENETICS, 2000, 26 (01) : 76 - 80
  • [3] PPARγ, the ultimate thrifty gene
    Auwerx, J
    [J]. DIABETOLOGIA, 1999, 42 (09) : 1033 - 1049
  • [4] Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene
    Beamer, BA
    Negri, C
    Yen, CJ
    Gavrilova, O
    Rumberger, JM
    Durcan, MJ
    Yarnall, DP
    Hawkins, AL
    Griffin, CA
    Burns, DK
    Roth, J
    Reitman, M
    Shuldiner, AR
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (03) : 756 - 759
  • [5] The metabolic syndrome and chronic kidney disease in US adults
    Chen, J
    Muntner, P
    Hamm, LL
    Jones, DW
    Batuman, V
    Fonseca, V
    Whelton, PK
    He, J
    [J]. ANNALS OF INTERNAL MEDICINE, 2004, 140 (03) : 167 - 174
  • [6] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [7] The Pro12Ala variant of peroxisome proliferator-activated receptor-γ2 (PPAR-γ2) is associated with measures of obesity in Mexican Americans
    Cole, SA
    Mitchell, BD
    Hsueh, WC
    Pineda, P
    Beamer, BA
    Shuldiner, AR
    Comuzzie, AG
    Blangero, J
    Hixson, JE
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (04) : 522 - 524
  • [8] A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
    Deeb, SS
    Fajas, L
    Nemoto, M
    Pihlajamäki, J
    Mykkänen, L
    Kuusisto, J
    Laakso, M
    Fujimoto, W
    Auwerx, J
    [J]. NATURE GENETICS, 1998, 20 (03) : 284 - 287
  • [9] Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes
    Doney, ASF
    Fischer, B
    Cecil, JE
    Boylan, K
    McGuigan, FE
    Ralston, SH
    Morris, AD
    Palmer, CNA
    [J]. DIABETOLOGIA, 2004, 47 (03) : 555 - 558
  • [10] The peroxisome poliferator-activated receptor-γ2 Pro12Ala variant -: Association with type 2 diabetes and trait differences
    Douglas, JA
    Erdos, MR
    Watanabe, RM
    Braun, A
    Johnston, CL
    Oeth, P
    Mohlke, KL
    Valle, TT
    Ehnholm, C
    Buchanan, TA
    Bergman, RN
    Collins, FS
    Boehnke, M
    Tuomilehto, J
    [J]. DIABETES, 2001, 50 (04) : 886 - 890